Orthocare Innovations, Oklahoma City, Oklahoma, announced that it has been awarded two new Phase II grants from the National Institutes of Health (NIH), under the Small Business Innovation Research program. The grants, with a combined total of more than $2.3 million, are both funded by the National Center for Medical Rehabilitation Research within the Eunice Kennedy Shriver National Institute of Child Health and Human Development.
A $1.2 million grant will fund research activities in the area of lower-limb prosthetics actuation through application of proprietary miniaturized hydraulic systems, or mesofluidic, which is core to the company’s Magellan™ microprocessor foot ankle system that is under development. It will also demonstrate the scalability of mesofluidics for special populations. Adam Arabian, PhD, PE, Orthocare’s director of product development, will serve as principal investigator on this project.
A $1.1 million grant builds on Orthocare’s Smart Pyramid™ and Compas™. Orthocare research scientist Toshiki Kobayashi, PhD, is the principal investigator on this grant.
“The battle for limited NIH resources is increasingly fierce in today’s hypercompetitive environment,” said Doug McCormack, Orthocare Innovations’ CEO. “These two new Phase II awards are testament to the strength of Orthocare’s research and development team, as well as its ability….”
